Search Results 621-630 of 19218 for alzheimers
... Alzheimer's disease based solely on biomarker evidence. Alzheimers Dement. 2025 Apr; 21 (4):e70068. View PubMed; Ghatamaneni S, Coleman C, Shin I, Bruinsma T ...
Cognitive disorders such as Alzheimer's disease, Lewy Body disease, frontotemporal dementia, mild cognitive impairment and rare dementias ...
“Alzheimer's disease is an epidemic affecting 35 million people worldwide,” says Dr. Ertekin-Taner. “It's going to escalate unless we can stop it or slow it ...
... Alzheimer's Disease Research Program, and Mayo Clinic Alzheimer's Disease Research Center. For a full list of authors, collaborating institutions and ...
The purpose of this study is to evaluate the effectiveness and safety of gantenerumab versus placebo in participants with early (prodromal to mild) Alzheimer's ...
Lecanemab-irmb injection is used to treat Alzheimer's disease. This medicine is to be given only by or under the supervision of your doctor. This product is ...
Ronald Peterson, neurologist and director of Mayo Clinic's Alzheimer's Disease Research Center, will join Dr. Steven DeKosky to present the keynote, "On the ...
Head or facial injury; Diseases that affect the central nervous system, such as Alzheimer's disease and Parkinson's disease.
Research shows as many as 1 in 5 people age 65 and older will develop mild cognitive impairment. Many of those will progress to Alzheimer's disease. But the new ...
... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.